Sign in Sign up for free

Cue Biopharma Inc Quick ratio

What is the Quick ratio of Cue Biopharma Inc?

The Quick ratio of Cue Biopharma Inc is 2.06

What is the definition of Quick ratio?



Quick ratio is liquidity ratio that measures a company’s ability to use its quick assets to meet its short-term obligations immediately.

mrq (most recent quarter)

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc

What does Cue Biopharma Inc do?

cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci

Companies with quick ratio similar to Cue Biopharma Inc